RPbio

알피바이오 · 314140

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$33.5M (₩46.2B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$98.7M

▲ +9.9% YoY

Operating profit · FY2025

US$3.7M

Turned profitable

Net income · FY2025

US$3.4M

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$109.5M(₩151B)	US$89.8M(₩124B)	US$98.7M(₩136.2B)
Operating profit	US$4.8M(₩6.6B)	−US$502.6K(−₩693.6M)	US$3.7M(₩5.1B)
Net income	US$3.9M(₩5.4B)	−US$657.3K(−₩907.1M)	US$3.4M(₩4.7B)

Revenue

Operating profit

Net income

ROE

4.4%

Debt/Eq

45.8%

Op. margin

3.7%

Net margin

3.4%

Rev. YoY

▲ +9.9%

Interactive price history isn't here yet. Would you use it?